These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20537948)

  • 61. The importance of genetic counselling in genome-wide sequencing.
    Elliott AM; Friedman JM
    Nat Rev Genet; 2018 Dec; 19(12):735-736. PubMed ID: 30283055
    [No Abstract]   [Full Text] [Related]  

  • 62. Digital health - a new medical cosmology? The case of 23andMe online genetic testing platform.
    Saukko P
    Sociol Health Illn; 2018 Nov; 40(8):1312-1326. PubMed ID: 29998537
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The phenotypic screening pendulum swings.
    Mullard A
    Nat Rev Drug Discov; 2015 Dec; 14(12):807-9. PubMed ID: 26620403
    [No Abstract]   [Full Text] [Related]  

  • 64. Impact of limited population diversity of genome-wide association studies.
    Haga SB
    Genet Med; 2010 Feb; 12(2):81-4. PubMed ID: 20057316
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Revealed identity: a study of the process of genetic counselling.
    Armstrong D; Michie S; Marteau T
    Soc Sci Med; 1998 Dec; 47(11):1653-8. PubMed ID: 9877335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comment on 'Cancer genetic counselling' by P. Mandich et al. (Ann Oncol 2005; 16: 171).
    Contegiacomo A; Pensabene M; Capuano I; Tauchmanova L; Federico M; Turchetti D; Cortesi L; Marchetti P; Ricevuto E; Cianci G; Barbieri V; Venuta S; Silingardi V
    Ann Oncol; 2005 Jul; 16(7):1208-9. PubMed ID: 15870089
    [No Abstract]   [Full Text] [Related]  

  • 67. Direct-to-consumer genetic testing: two sides of the coin.
    Farkas DH; Holland CA
    J Mol Diagn; 2009 Jul; 11(4):263-5. PubMed ID: 19541920
    [No Abstract]   [Full Text] [Related]  

  • 68. The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease.
    Janssens AC; Wilde AA; van Langen IM
    Neth Heart J; 2011 Feb; 19(2):85-88. PubMed ID: 21461037
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic counselling for personalised medicine.
    Clarke A; Thirlaway K
    Hum Genet; 2011 Jul; 130(1):27-31. PubMed ID: 21505858
    [No Abstract]   [Full Text] [Related]  

  • 70. Recent advances in miRNA-based diagnostic applications.
    Sempere LF
    Expert Rev Mol Diagn; 2012 Jul; 12(6):557-9. PubMed ID: 22845475
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Addressing gaps in physician education using personal genomic testing.
    Sharp RR; Goldlust ME; Eng C
    Genet Med; 2011 Aug; 13(8):750-1. PubMed ID: 21814069
    [No Abstract]   [Full Text] [Related]  

  • 72. Captious certainties: makings, meanings and misreadings of consumer-oriented genetic testing.
    Paul NW; Banerjee M; Michl S
    J Community Genet; 2014 Jan; 5(1):81-7. PubMed ID: 24203529
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic testing: predictive value of genotyping for diagnosis and management of disease.
    Ozgüç M
    EPMA J; 2011 Jun; 2(2):173-9. PubMed ID: 23199147
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Cancer risk prediction in post-genome-wide association study era].
    Jin G; Shen H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Oct; 36(10):1045-6. PubMed ID: 26837340
    [No Abstract]   [Full Text] [Related]  

  • 75. Direct-to-consumer genetic testing services: what are the medical benefits?
    Frebourg T
    Eur J Hum Genet; 2012 May; 20(5):483. PubMed ID: 22215420
    [No Abstract]   [Full Text] [Related]  

  • 76. Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions.
    Yan L; Shi J; Zhu J
    Discov Oncol; 2024 Jul; 15(1):294. PubMed ID: 39031216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Breast cancer screening and early diagnosis in Chinese women.
    Ding R; Xiao Y; Mo M; Zheng Y; Jiang YZ; Shao ZM
    Cancer Biol Med; 2022 Apr; 19(4):450-67. PubMed ID: 35380032
    [TBL] [Abstract][Full Text] [Related]  

  • 78. On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
    Amara N; Blouin-Bougie J; Bouthillier D; Simard J
    Pharmacogenomics J; 2018 Apr; 18(2):308-318. PubMed ID: 28607504
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining.
    Keogh LA; Niven H; Rutstein A; Flander L; Gaff C; Jenkins M
    J Behav Med; 2017 Aug; 40(4):583-594. PubMed ID: 28197815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gatekeeper role of gastroenterologists and surgeons in recognising and discussing familial colorectal cancer.
    Douma KF; Dekker E; Smets EM; Aalfs CM
    Fam Cancer; 2016 Apr; 15(2):231-40. PubMed ID: 26687117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.